Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

Abstract

The MLL (Mixed Lineage Leukemia) gene is a common target for chromosomal translocations associated with human acute leukemias. These translocations result in a gain of MLL function by generating novel chimeric proteins containing the amino-terminus of MLL fused in-frame with one of 30 distinct partner proteins. Structure/function studies using an in vitro myeloid progenitor immortalization assay have revealed that at least four nuclear partner proteins contribute transcriptional effector properties to MLL to produce a range of chimeric transcription factors with leukemogenic potential. Mouse models suggest that expression of an MLL fusion protein is necessary but not sufficient for leukemogenesis. Interestingly, whilst all MLL fusion proteins tested so far phenocopy each other with respect to in vitro immortalization, the latency period required for the onset of acute leukemia in vivo is variable and partner protein dependent. We discuss potential mechanisms that may account for the ability of distinct MLL fusion proteins to promote short or long latency leukemogenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ayton, Cleary . 2001 Transcription Factors: Normal and Malignant Development of Blood Cells Ravid K and Licht J (eds) Wiley-Liss: New York pp. 447–463

    Google Scholar 

  • Bahri SM, Chia W, Yang X . 2001 Mech. Dev. 100: 291–301

  • Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon, M . 1994 Cell 79: 885–892

  • Bannister AJ, Kouzarides T . 1996 Nature 384: 641–643

  • Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF, Bohle RM, Harbott J, Repp R, Jaeger U, Viehmann S, Henn T, Korth P, Scharr D, Lampert F . 2000 Proc. Natl. Acad. Sci. USA 97: 9168–9173

  • Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE . 1996 Nat. Genet. 14: 33–41

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME . 1999 Cell 96: 857–868

  • Cairns BR, Henry NL, Kornberg RD . 1996 Mol. Cell. Biol. 16: 3308–3316

  • Caligiuri MA, Strout MP, Schichman SA, Mrozek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD . 1996 Cancer Res. 56: 1418–1425

  • Caslini C, Shilatifard A, Yang L, Hess JL . 2000 Proc. Natl. Acad. Sci. USA 97: 2797–2802

  • Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP . 1996 Cell 87: 687–696

  • Chaplin T, Ayton P, Bernard OA, Saha V, Della Valle V, Hillion J, Gregorini A, Lillington D, Berger R, Young BD . 1995a Blood 85: 1435–1441

  • Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD . 1995b Blood 86: 2073–2076

  • Cleary ML . 1991 Cell 66: 619–622

  • Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH . 1996 Cell 85: 853–861

  • Croce CM . 1999 Cancer Res. 59: 1778s–1783s

  • Cross SH, Meehan RR, Nan X, Bird A . 1997 Nat. Genet. 16: 256–259

  • Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM . 1999 Nature 399: 491–496

  • DiMartino JF, Miller T, Ayton PM, Landewe T, Hess JL, Cleary ML, Shilatifard A . 2000 Blood 96: 3887–3893

  • Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, Smith AJ, Rabbitts TH . 1999 EMBO J. 18: 3564–3574

  • Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH . 2000 EMBO J. 19: 843–851

  • Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ . 1993 Proc. Natl. Acad. Sci. USA 90: 7884–7888

  • Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK . 1996 Proc. Natl. Acad. Sci. USA 93: 4804–4809

  • Dreyling MH, Schrader K, Fonatsch C, Schlegelberger B, Haase D, Schoch C, Ludwig W, Loffler H, Buchner T, Wormann B, Hiddemann W, Bohlander SK . 1998 Blood 91: 4662–4667

  • Felix CA, Lange BJ . 1999 Oncologist 4: 225–240

  • Galoian K, Milne T, Brock H, Shilatifard A, Slany R, Hess J . 2000 Blood 96: 457a

  • Gecz J, Gedeon AK, Sutherland GR, Mulley JC . 1996 Nat. Genet. 13: 105–108

  • Gu Y, Shen Y, Gibbs RA, Nelson DL . 1996 Nat. Genet. 13: 109–113

  • Hayette S, Tigaud I, Vanier A, Martel S, Corbo L, Charrin C, Beillard E, Deleage G, Magaud JP, Rimokh R . 2000 Oncogene 19: 4446–4450

  • He L, Bhaumik M, Tribioli C, Rego EM, Ivins S, Zelent A, Pandolfi PP . 2000 Mol. Cell 6: 1131–1141

  • Hendrich B, Bird A . 1998 Mol. Cell. Biol. 18: 6538–6547

  • Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ . 1997 Blood 90: 1799–1806

  • Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM, Clore GM . 1997 Nat. Struct. Biol. 4: 657–665

  • Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M, Hayashi Y . 1997 Blood 90: 4699–4704

  • Isnard P, Core N, Naquet P, Djabali M . 2000 Blood 96: 705–710

  • Joh T, Kagami Y, Yamamoto K, Segawa T, Takizawa J, Takahashi T, Ueda R, Seto M . 1996 Oncogene 13: 1945–1953

  • Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S, Secker-Walker LM . 1998 Leukemia 12: 779–787

  • Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM . 1999 Nature 398: 630–634

  • Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S, Bloomfield CD, Caligiuri MA . 2000 Proc. Natl. Acad. Sci. USA 97: 2145–2150

  • Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, Yamamoto D, Prasad R, Croce C, Canaani E, Kaibuchi K . 1996 J. Biol. Chem. 271: 607–610

  • Kuwada N, Kimura F, Matsumura T, Yamashita T, Nakamura Y, Wakimoto N, Ikeda T, Sato K, Motoyoshi K . 2001 Cancer Res. 61: 2665–2669

  • Lavau C, Szilvassy SJ, Slany R, Cleary ML . 1997 EMBO J. 16: 4226–4237

  • Lavau C, Du C, Thirman M, Zeleznik-Le N . 2000a EMBO J. 19: 4655–4664

  • Lavau C, Luo RT, Du C, Thirman MJ . 2000b Proc. Natl. Acad. Sci. USA 97: 10984–10989

  • Lavau C, Luo RT, Simeone F, Polak PE, Du C, Kawamata S, Thirman MJ . 2000c Blood 96: 573a

  • Li Q, Frestedt JL, Kersey JH . 1998 Blood 92: 3841–3847

  • Lochner K, Siegler G, Fuhrer M, Greil J, Beck JD, Fey GH, Marschalek R . 1996 Cancer Res. 56: 2171–2177

  • Ma C, Staudt LM . 1996 Blood 87: 734–745

  • Mahgoub N, Parker RI, Hosler MR, Close P, Winick NJ, Masterson M, Shannon KM, Felix CA . 1998 Genes Chromo. Cancer 21: 270–275

  • Martinez-Balbas MA, Bannister AJ, Martin K, Haus-Seuffert P, Meisterernst M, Kouzarides T . 1998 EMBO J. 17: 2886–2893

  • Matsuo T, Takahashi K, Kondo S, Kaibuchi K, Yamamoto D . 1997 Development 124: 2671–2680

  • Medema RH, Kops GJ, Bos JL, Burgering BM . 2000 Nature 404: 782–787

  • Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH, Addya K, Leonard DG, Kushner BH, Williams TM, Lange BJ, Felix CA . 2000 Proc. Natl. Acad. Sci. USA 97: 2814–2819

  • Mitelman F, Johansson B, Mertens F . 1994 Catalogue of Chromosome Abberations in Cancer 5th Edn Wiley-Liss: New York

    Google Scholar 

  • Miller T, Williams K, Johnstone RW, Shilatifard A . 2000 J. Biol. Chem. 275: 32052–32056

  • Miyamoto H, Nihonmatsu I, Kondo S, Ueda R, Togashi S, Hirata K, Ikegami Y, Yamamoto D . 1995 Genes Dev. 9: 612–625

  • Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML . 1993 Blood 81: 1124–1131

  • Morrissey JJ, Raney S, Cleary ML . 1997 Leuk. Res. 21: 911–917

  • Mountford P, Zevnik B, Duwel A, Nichols J, Li M, Dani C, Robertson M, Chambers I, Smith A . 1994 Proc. Natl. Acad. Sci. USA 91: 4303–4307

  • Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC, Croce CM, Canaani, E . 1993 Proc. Natl. Acad. Sci. USA 90: 4631–4635

  • Nilson I, Reichel M, Ennas MG, Greim R, Knorr C, Siegler G, Greil J, Fey GH, Marschalek R . 1997 Br. J. Haematol. 98: 157–169

  • Nissen MS, Langan TA, Reeves R . 1991 J. Biol. Chem. 266: 19945–19952

  • Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G . 1997 Nature 389: 994–999

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . 1996 Cell 84: 321–330

  • Paradis S, Ruvkun G . 1998 Genes Dev. 12: 2488–2498

  • Pegram LD, Megonigal MD, Lange BJ, Nowell PC, Rowley JD, Rappaport EF, Felix CA . 2000 Blood 96: 4360–4362

  • Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ, Breuning MH . 1995 Nature 376: 348–351

  • Prasad R, Yano T, Sorio C, Nakamura T, Rallapalli R, Gu Y, Leshkowitz D, Croce CM, Canaani E . 1995 Proc. Natl. Acad. Sci. USA 92: 12160–12164

  • Rabbitts TH . 1994 Nature 372: 143–149

  • Reeves R, Nissen MS . 1990 J. Biol. Chem. 265: 8573–8582

  • Reeves R, Langan TA, Nissen MS . 1991 Proc. Natl. Acad. Sci. USA 88: 1671–1675

  • Rowley JD . 1992 Genes Chrom. Cancer 5: 264–266

  • Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J, Nakamura T, Croce CM, Mazo A, Canaani E . 1998 Proc. Natl. Acad. Sci. USA 95: 4152–4157

  • Rubnitz JE, Morrissey J, Savage PA, Cleary ML . 1994 Blood 84: 1747–1752

  • Sano K, Hayakawa A, Piao JH, Kosaka Y, Nakamura H . 2000 Blood 95: 1066–1068

  • Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM . 1994 Proc. Natl. Acad. Sci. USA 91: 6236–6239

  • Secker-Walker LM . 1998 Leukemia 12: 776–778

  • Shi Y, Alin K, Goff SP . 1995 Genes Dev. 9: 2583–2597

  • Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW . 1996 Science 271: 1873–1876

  • Shilatifard A, Duan DR, Haque D, Florence C, Schubach WH, Conaway JW, Conaway RC . 1997a Proc. Natl. Acad. Sci. USA 94: 3639–3643

  • Shilatifard A, Haque D, Conaway RC, Conaway JW . 1997b J. Biol. Chem. 272: 22355–22363

  • Slany RK, Lavau C, Cleary ML . 1998 Mol. Cell. Biol. 18: 122–129

  • Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ . 1997 Proc. Natl. Acad. Sci. USA 94: 8732–8737

  • Strout MP, Mrozek K, Heinonen K, Sait SN, Shows TB, Aplan PD . 1996 Genes Chrom. Cancer 16: 204–210

  • Su M, Wisotzkey R, Newfeld S . 2001 Genetics 157: 717–725

  • Syntichaki P, Topalidou I, Thireos G . 2000 Nature 404: 414–417

  • Taki T, Sako M, Tsuchida M, Hayashi Y . 1997 Blood 89: 3945–3950

  • Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M, Hayashi Y . 1998 Blood 92: 1125–1130

  • Taki T, Kano H, Taniwaki M, Sako M, Yanagisawa M, Hayashi Y . 1999 Proc. Natl. Acad. Sci. USA 96: 14535–14540

  • Tang AH, Neufeld TP, Rubin GM, Muller HA . 2001 Development 128: 801–813

  • Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD . 1994 Proc. Natl. Acad. Sci. USA 91: 12110–12114

  • Tkachuk DC, Kohler S, Cleary ML . 1992 Cell 71: 691–700

  • Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH . 1994 Nature 371: 221–226

  • Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O . 1998 Nature 394: 203–206

  • von Bergh A, Beverloo B, Slater R, Groot A, Rombout P, Kluin P, Schuuring E . 2000 Blood 96: 693a

  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . 1996 Proc. Natl. Acad. Sci. USA 93: 3444–3449

  • Wittwer F, van der Straten A, Keleman K, Dickson BJ, Hafen E . 2001 Development 128: 791–800

  • Yagi H, Deguchi K, Aono A, Tani Y, Kishimoto T, Komori T . 1998 Blood 92: 108–117

  • Yano T, Nakamura T, Blechman J, Sorio C, Dang CV, Geiger B, Canaani E . 1997 Proc. Natl. Acad. Sci. USA 94: 7286–7291

  • Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R . 1998 Cell 93: 361–372

  • Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE . 1997 Natl. Genet. 15: 303–306

  • Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ . 1995 Nature 378: 505–508

  • Yu BD, Hanson RD, Hess JL, Horning SE, Korsmeyer SJ . 1998 Proc. Natl. Acad. Sci. USA 95: 10632–10636

  • Zeleznik-Le NJ, Harden AM, Rowley JD . 1994 Proc. Natl. Acad. Sci. USA 91: 10610–10614

Download references

Acknowledgements

We thank our colleagues in the Cleary Lab for many helpful discussions and sharing of unpublished results. Our studies are supported in part by funds from the National Cancer Institute.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayton, P., Cleary, M. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20, 5695–5707 (2001). https://doi.org/10.1038/sj.onc.1204639

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204639

Keywords

This article is cited by

Search

Quick links